Meeting NewsVideo

Olympus aims to improve endoscopy through partnership with ai4gi

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Healio Gastroenterology and Liver Disease spoke with Kurt Heine, endoscopy division group vice president of Olympus Corporation for the Americas, about the recently announced codevelopment agreement between ai4gi and Olympus for endoscopic development.

“Artificial intelligence is all around us right now and in everything we do on a daily basis, so an entrance into health care makes perfect sense,” Heine said. “We want to try to address the triple aim of trying to improve clinical outcomes, patient satisfaction and the cost of the procedure. We feel this [agreement] will help us attain those different things.”

To hear more about ai4gi, watch the video with company founder Michael Byrne, MD, and the video with ai4gi’s advisory board chairman Douglas K. Rex, MD.

Disclosure: Heine is an employee of Olympus Corporation of the Americas.

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Healio Gastroenterology and Liver Disease spoke with Kurt Heine, endoscopy division group vice president of Olympus Corporation for the Americas, about the recently announced codevelopment agreement between ai4gi and Olympus for endoscopic development.

“Artificial intelligence is all around us right now and in everything we do on a daily basis, so an entrance into health care makes perfect sense,” Heine said. “We want to try to address the triple aim of trying to improve clinical outcomes, patient satisfaction and the cost of the procedure. We feel this [agreement] will help us attain those different things.”

To hear more about ai4gi, watch the video with company founder Michael Byrne, MD, and the video with ai4gi’s advisory board chairman Douglas K. Rex, MD.

Disclosure: Heine is an employee of Olympus Corporation of the Americas.

    See more from Digestive Disease Week